nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone—Prednisolone—ankylosing spondylitis	0.267	1	CrCtD
Testosterone—breast cancer—Betamethasone—ankylosing spondylitis	0.127	0.5	CpDpCtD
Testosterone—breast cancer—Dexamethasone—ankylosing spondylitis	0.127	0.5	CpDpCtD
Testosterone—CYP3A43—Dexamethasone—ankylosing spondylitis	0.0231	0.118	CbGbCtD
Testosterone—CYP11A1—Dexamethasone—ankylosing spondylitis	0.0167	0.0856	CbGbCtD
Testosterone—CYP19A1—Betamethasone—ankylosing spondylitis	0.0134	0.0686	CbGbCtD
Testosterone—Exemestane—Methylprednisolone—ankylosing spondylitis	0.0108	0.0444	CrCrCtD
Testosterone—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0103	0.0529	CbGbCtD
Testosterone—Exemestane—Prednisone—ankylosing spondylitis	0.00985	0.0405	CrCrCtD
Testosterone—SLCO1A2—Prednisone—ankylosing spondylitis	0.00975	0.05	CbGbCtD
Testosterone—Exemestane—Prednisolone—ankylosing spondylitis	0.00961	0.0396	CrCrCtD
Testosterone—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0096	0.0492	CbGbCtD
Testosterone—ABCG2—Sulfasalazine—ankylosing spondylitis	0.00914	0.0469	CbGbCtD
Testosterone—CYP19A1—Dexamethasone—ankylosing spondylitis	0.00778	0.0399	CbGbCtD
Testosterone—Potassium Canrenoate—Prednisone—ankylosing spondylitis	0.00745	0.0307	CrCrCtD
Testosterone—Potassium Canrenoate—Prednisolone—ankylosing spondylitis	0.00728	0.0299	CrCrCtD
Testosterone—SLC22A7—Methotrexate—ankylosing spondylitis	0.00698	0.0358	CbGbCtD
Testosterone—Medrysone—Methylprednisolone—ankylosing spondylitis	0.0069	0.0284	CrCrCtD
Testosterone—Medroxyprogesterone Acetate—Methylprednisolone—ankylosing spondylitis	0.00665	0.0273	CrCrCtD
Testosterone—Danazol—Prednisone—ankylosing spondylitis	0.00629	0.0259	CrCrCtD
Testosterone—Medrysone—Prednisolone—ankylosing spondylitis	0.00614	0.0253	CrCrCtD
Testosterone—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.00609	0.0312	CbGbCtD
Testosterone—Hydrocortamate—Methylprednisolone—ankylosing spondylitis	0.006	0.0247	CrCrCtD
Testosterone—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.00581	0.0239	CrCrCtD
Testosterone—Testolactone—Methylprednisolone—ankylosing spondylitis	0.00564	0.0232	CrCrCtD
Testosterone—Testolactone—Dexamethasone—ankylosing spondylitis	0.00555	0.0228	CrCrCtD
Testosterone—Testolactone—Betamethasone—ankylosing spondylitis	0.00555	0.0228	CrCrCtD
Testosterone—Hydrocortamate—Prednisone—ankylosing spondylitis	0.00548	0.0225	CrCrCtD
Testosterone—Testolactone—Triamcinolone—ankylosing spondylitis	0.00542	0.0223	CrCrCtD
Testosterone—Hydrocortamate—Prednisolone—ankylosing spondylitis	0.00534	0.022	CrCrCtD
Testosterone—Cortisone acetate—Prednisone—ankylosing spondylitis	0.00531	0.0218	CrCrCtD
Testosterone—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.00518	0.0213	CrCrCtD
Testosterone—Testolactone—Prednisone—ankylosing spondylitis	0.00515	0.0212	CrCrCtD
Testosterone—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.0051	0.021	CrCrCtD
Testosterone—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.0051	0.021	CrCrCtD
Testosterone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.00507	0.026	CbGbCtD
Testosterone—Fludrocortisone—Methylprednisolone—ankylosing spondylitis	0.00505	0.0208	CrCrCtD
Testosterone—ALB—Prednisone—ankylosing spondylitis	0.00504	0.0258	CbGbCtD
Testosterone—Testolactone—Prednisolone—ankylosing spondylitis	0.00503	0.0207	CrCrCtD
Testosterone—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.00499	0.0205	CrCrCtD
Testosterone—Fludrocortisone—Betamethasone—ankylosing spondylitis	0.00497	0.0205	CrCrCtD
Testosterone—Fludrocortisone—Dexamethasone—ankylosing spondylitis	0.00497	0.0205	CrCrCtD
Testosterone—SLCO1A2—Methotrexate—ankylosing spondylitis	0.00489	0.0251	CbGbCtD
Testosterone—Fludrocortisone—Triamcinolone—ankylosing spondylitis	0.00486	0.02	CrCrCtD
Testosterone—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.00462	0.019	CrCrCtD
Testosterone—Fludrocortisone—Prednisone—ankylosing spondylitis	0.00461	0.019	CrCrCtD
Testosterone—ABCG2—Dexamethasone—ankylosing spondylitis	0.00456	0.0234	CbGbCtD
Testosterone—Progesterone—Prednisolone—ankylosing spondylitis	0.0045	0.0185	CrCrCtD
Testosterone—Fludrocortisone—Prednisolone—ankylosing spondylitis	0.0045	0.0185	CrCrCtD
Testosterone—Methyltestosterone—Prednisone—ankylosing spondylitis	0.00449	0.0185	CrCrCtD
Testosterone—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.00439	0.0181	CrCrCtD
Testosterone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.00435	0.0223	CbGbCtD
Testosterone—Prednisolone—Methylprednisolone—ankylosing spondylitis	0.00429	0.0177	CrCrCtD
Testosterone—SLC22A8—Methotrexate—ankylosing spondylitis	0.00426	0.0218	CbGbCtD
Testosterone—Prednisolone—Betamethasone—ankylosing spondylitis	0.00422	0.0174	CrCrCtD
Testosterone—Prednisolone—Dexamethasone—ankylosing spondylitis	0.00422	0.0174	CrCrCtD
Testosterone—CYP1A1—Dexamethasone—ankylosing spondylitis	0.00421	0.0216	CbGbCtD
Testosterone—Prednisolone—Triamcinolone—ankylosing spondylitis	0.00413	0.017	CrCrCtD
Testosterone—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.00412	0.017	CrCrCtD
Testosterone—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.00405	0.0167	CrCrCtD
Testosterone—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.00405	0.0167	CrCrCtD
Testosterone—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.00396	0.0163	CrCrCtD
Testosterone—Prednisolone—Prednisone—ankylosing spondylitis	0.00392	0.0161	CrCrCtD
Testosterone—Hydrocortisone—Prednisone—ankylosing spondylitis	0.00376	0.0155	CrCrCtD
Testosterone—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.00367	0.0151	CrCrCtD
Testosterone—ABCG2—Methotrexate—ankylosing spondylitis	0.00367	0.0188	CbGbCtD
Testosterone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.00337	0.0173	CbGbCtD
Testosterone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.00337	0.0173	CbGbCtD
Testosterone—CYP2C19—Prednisone—ankylosing spondylitis	0.00327	0.0167	CbGbCtD
Testosterone—CYP2B6—Dexamethasone—ankylosing spondylitis	0.00321	0.0164	CbGbCtD
Testosterone—ABCB1—Betamethasone—ankylosing spondylitis	0.00283	0.0145	CbGbCtD
Testosterone—ABCB1—Prednisolone—ankylosing spondylitis	0.00279	0.0143	CbGbCtD
Testosterone—ABCB1—Prednisone—ankylosing spondylitis	0.00264	0.0135	CbGbCtD
Testosterone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00261	0.0134	CbGbCtD
Testosterone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.00253	0.013	CbGbCtD
Testosterone—ALB—Methotrexate—ankylosing spondylitis	0.00253	0.013	CbGbCtD
Testosterone—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00243	0.0125	CbGbCtD
Testosterone—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00204	0.0104	CbGbCtD
Testosterone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00198	0.0101	CbGbCtD
Testosterone—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0017	0.00869	CbGbCtD
Testosterone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0017	0.00868	CbGbCtD
Testosterone—CYP3A4—Prednisolone—ankylosing spondylitis	0.00167	0.00857	CbGbCtD
Testosterone—ABCB1—Dexamethasone—ankylosing spondylitis	0.00165	0.00843	CbGbCtD
Testosterone—CYP3A4—Prednisone—ankylosing spondylitis	0.00158	0.00809	CbGbCtD
Testosterone—ABCB1—Methotrexate—ankylosing spondylitis	0.00132	0.00678	CbGbCtD
Testosterone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.000986	0.00505	CbGbCtD
Testosterone—Myalgia—Methylprednisolone—ankylosing spondylitis	3.36e-05	0.000804	CcSEcCtD
Testosterone—Eye disorder—Prednisone—ankylosing spondylitis	3.36e-05	0.000803	CcSEcCtD
Testosterone—Anxiety—Methylprednisolone—ankylosing spondylitis	3.35e-05	0.000801	CcSEcCtD
Testosterone—Infestation NOS—Methotrexate—ankylosing spondylitis	3.34e-05	0.0008	CcSEcCtD
Testosterone—Infestation—Methotrexate—ankylosing spondylitis	3.34e-05	0.0008	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	3.34e-05	0.000798	CcSEcCtD
Testosterone—Depression—Methotrexate—ankylosing spondylitis	3.33e-05	0.000797	CcSEcCtD
Testosterone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	3.33e-05	0.000797	CcSEcCtD
Testosterone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	3.33e-05	0.000797	CcSEcCtD
Testosterone—Discomfort—Triamcinolone—ankylosing spondylitis	3.33e-05	0.000796	CcSEcCtD
Testosterone—Discomfort—Methylprednisolone—ankylosing spondylitis	3.32e-05	0.000794	CcSEcCtD
Testosterone—Dry mouth—Triamcinolone—ankylosing spondylitis	3.29e-05	0.000788	CcSEcCtD
Testosterone—Renal failure—Methotrexate—ankylosing spondylitis	3.29e-05	0.000786	CcSEcCtD
Testosterone—Angioedema—Dexamethasone—ankylosing spondylitis	3.28e-05	0.000785	CcSEcCtD
Testosterone—Angioedema—Betamethasone—ankylosing spondylitis	3.28e-05	0.000785	CcSEcCtD
Testosterone—Stomatitis—Methotrexate—ankylosing spondylitis	3.26e-05	0.00078	CcSEcCtD
Testosterone—Angiopathy—Prednisone—ankylosing spondylitis	3.26e-05	0.000779	CcSEcCtD
Testosterone—Confusional state—Methylprednisolone—ankylosing spondylitis	3.25e-05	0.000777	CcSEcCtD
Testosterone—Immune system disorder—Prednisone—ankylosing spondylitis	3.24e-05	0.000776	CcSEcCtD
Testosterone—Malaise—Dexamethasone—ankylosing spondylitis	3.24e-05	0.000774	CcSEcCtD
Testosterone—Malaise—Betamethasone—ankylosing spondylitis	3.24e-05	0.000774	CcSEcCtD
Testosterone—Oedema—Triamcinolone—ankylosing spondylitis	3.23e-05	0.000772	CcSEcCtD
Testosterone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	3.23e-05	0.000772	CcSEcCtD
Testosterone—Vertigo—Dexamethasone—ankylosing spondylitis	3.22e-05	0.000772	CcSEcCtD
Testosterone—Vertigo—Betamethasone—ankylosing spondylitis	3.22e-05	0.000772	CcSEcCtD
Testosterone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	3.22e-05	0.000771	CcSEcCtD
Testosterone—Syncope—Dexamethasone—ankylosing spondylitis	3.22e-05	0.00077	CcSEcCtD
Testosterone—Syncope—Betamethasone—ankylosing spondylitis	3.22e-05	0.00077	CcSEcCtD
Testosterone—Infection—Triamcinolone—ankylosing spondylitis	3.21e-05	0.000767	CcSEcCtD
Testosterone—Sweating—Methotrexate—ankylosing spondylitis	3.2e-05	0.000767	CcSEcCtD
Testosterone—Infection—Methylprednisolone—ankylosing spondylitis	3.2e-05	0.000766	CcSEcCtD
Testosterone—Haematuria—Methotrexate—ankylosing spondylitis	3.19e-05	0.000763	CcSEcCtD
Testosterone—Shock—Triamcinolone—ankylosing spondylitis	3.18e-05	0.00076	CcSEcCtD
Testosterone—Insomnia—Prednisolone—ankylosing spondylitis	3.17e-05	0.00076	CcSEcCtD
Testosterone—Alopecia—Prednisone—ankylosing spondylitis	3.17e-05	0.000759	CcSEcCtD
Testosterone—Shock—Methylprednisolone—ankylosing spondylitis	3.17e-05	0.000758	CcSEcCtD
Testosterone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	3.16e-05	0.000756	CcSEcCtD
Testosterone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	3.16e-05	0.000756	CcSEcCtD
Testosterone—Loss of consciousness—Betamethasone—ankylosing spondylitis	3.15e-05	0.000755	CcSEcCtD
Testosterone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	3.15e-05	0.000755	CcSEcCtD
Testosterone—Paraesthesia—Prednisolone—ankylosing spondylitis	3.15e-05	0.000754	CcSEcCtD
Testosterone—Tachycardia—Triamcinolone—ankylosing spondylitis	3.15e-05	0.000754	CcSEcCtD
Testosterone—Mental disorder—Prednisone—ankylosing spondylitis	3.15e-05	0.000753	CcSEcCtD
Testosterone—Tachycardia—Methylprednisolone—ankylosing spondylitis	3.14e-05	0.000752	CcSEcCtD
Testosterone—Skin disorder—Methylprednisolone—ankylosing spondylitis	3.13e-05	0.000749	CcSEcCtD
Testosterone—Malnutrition—Prednisone—ankylosing spondylitis	3.13e-05	0.000748	CcSEcCtD
Testosterone—Erythema—Prednisone—ankylosing spondylitis	3.13e-05	0.000748	CcSEcCtD
Testosterone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	3.12e-05	0.000747	CcSEcCtD
Testosterone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	3.11e-05	0.000745	CcSEcCtD
Testosterone—Hypertension—Dexamethasone—ankylosing spondylitis	3.1e-05	0.000741	CcSEcCtD
Testosterone—Hypertension—Betamethasone—ankylosing spondylitis	3.1e-05	0.000741	CcSEcCtD
Testosterone—Myalgia—Betamethasone—ankylosing spondylitis	3.06e-05	0.000731	CcSEcCtD
Testosterone—Myalgia—Dexamethasone—ankylosing spondylitis	3.06e-05	0.000731	CcSEcCtD
Testosterone—Anxiety—Dexamethasone—ankylosing spondylitis	3.04e-05	0.000729	CcSEcCtD
Testosterone—Anxiety—Betamethasone—ankylosing spondylitis	3.04e-05	0.000729	CcSEcCtD
Testosterone—Discomfort—Betamethasone—ankylosing spondylitis	3.02e-05	0.000722	CcSEcCtD
Testosterone—Discomfort—Dexamethasone—ankylosing spondylitis	3.02e-05	0.000722	CcSEcCtD
Testosterone—Haemoglobin—Methotrexate—ankylosing spondylitis	3.02e-05	0.000722	CcSEcCtD
Testosterone—Pain—Prednisolone—ankylosing spondylitis	3e-05	0.000718	CcSEcCtD
Testosterone—Haemorrhage—Methotrexate—ankylosing spondylitis	3e-05	0.000718	CcSEcCtD
Testosterone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	2.96e-05	0.000709	CcSEcCtD
Testosterone—Urethral disorder—Methotrexate—ankylosing spondylitis	2.94e-05	0.000704	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	2.94e-05	0.000704	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	2.93e-05	0.000702	CcSEcCtD
Testosterone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	2.93e-05	0.000701	CcSEcCtD
Testosterone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	2.93e-05	0.000701	CcSEcCtD
Testosterone—Oedema—Dexamethasone—ankylosing spondylitis	2.93e-05	0.000701	CcSEcCtD
Testosterone—Oedema—Betamethasone—ankylosing spondylitis	2.93e-05	0.000701	CcSEcCtD
Testosterone—Insomnia—Triamcinolone—ankylosing spondylitis	2.92e-05	0.000699	CcSEcCtD
Testosterone—Insomnia—Methylprednisolone—ankylosing spondylitis	2.91e-05	0.000697	CcSEcCtD
Testosterone—Infection—Betamethasone—ankylosing spondylitis	2.91e-05	0.000696	CcSEcCtD
Testosterone—Infection—Dexamethasone—ankylosing spondylitis	2.91e-05	0.000696	CcSEcCtD
Testosterone—Ill-defined disorder—Prednisone—ankylosing spondylitis	2.9e-05	0.000694	CcSEcCtD
Testosterone—Paraesthesia—Triamcinolone—ankylosing spondylitis	2.9e-05	0.000694	CcSEcCtD
Testosterone—Feeling abnormal—Prednisolone—ankylosing spondylitis	2.89e-05	0.000692	CcSEcCtD
Testosterone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	2.89e-05	0.000692	CcSEcCtD
Testosterone—Anaemia—Prednisone—ankylosing spondylitis	2.89e-05	0.000691	CcSEcCtD
Testosterone—Shock—Dexamethasone—ankylosing spondylitis	2.88e-05	0.000689	CcSEcCtD
Testosterone—Shock—Betamethasone—ankylosing spondylitis	2.88e-05	0.000689	CcSEcCtD
Testosterone—Dyspnoea—Triamcinolone—ankylosing spondylitis	2.88e-05	0.000689	CcSEcCtD
Testosterone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	2.87e-05	0.000687	CcSEcCtD
Testosterone—Nervous system disorder—Betamethasone—ankylosing spondylitis	2.87e-05	0.000687	CcSEcCtD
Testosterone—Agitation—Prednisone—ankylosing spondylitis	2.87e-05	0.000687	CcSEcCtD
Testosterone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	2.87e-05	0.000686	CcSEcCtD
Testosterone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	2.87e-05	0.000686	CcSEcCtD
Testosterone—Tachycardia—Betamethasone—ankylosing spondylitis	2.86e-05	0.000684	CcSEcCtD
Testosterone—Tachycardia—Dexamethasone—ankylosing spondylitis	2.86e-05	0.000684	CcSEcCtD
Testosterone—Angioedema—Prednisone—ankylosing spondylitis	2.86e-05	0.000683	CcSEcCtD
Testosterone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	2.83e-05	0.000678	CcSEcCtD
Testosterone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	2.83e-05	0.000678	CcSEcCtD
Testosterone—Malaise—Prednisone—ankylosing spondylitis	2.82e-05	0.000674	CcSEcCtD
Testosterone—Vertigo—Prednisone—ankylosing spondylitis	2.81e-05	0.000672	CcSEcCtD
Testosterone—Eye disorder—Methotrexate—ankylosing spondylitis	2.8e-05	0.000671	CcSEcCtD
Testosterone—Syncope—Prednisone—ankylosing spondylitis	2.8e-05	0.000671	CcSEcCtD
Testosterone—Tinnitus—Methotrexate—ankylosing spondylitis	2.8e-05	0.000669	CcSEcCtD
Testosterone—Urticaria—Prednisolone—ankylosing spondylitis	2.79e-05	0.000667	CcSEcCtD
Testosterone—Cardiac disorder—Methotrexate—ankylosing spondylitis	2.78e-05	0.000666	CcSEcCtD
Testosterone—Fatigue—Triamcinolone—ankylosing spondylitis	2.78e-05	0.000666	CcSEcCtD
Testosterone—Fatigue—Methylprednisolone—ankylosing spondylitis	2.78e-05	0.000664	CcSEcCtD
Testosterone—Pain—Triamcinolone—ankylosing spondylitis	2.76e-05	0.00066	CcSEcCtD
Testosterone—Loss of consciousness—Prednisone—ankylosing spondylitis	2.75e-05	0.000657	CcSEcCtD
Testosterone—Angiopathy—Methotrexate—ankylosing spondylitis	2.72e-05	0.000651	CcSEcCtD
Testosterone—Immune system disorder—Methotrexate—ankylosing spondylitis	2.71e-05	0.000648	CcSEcCtD
Testosterone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	2.7e-05	0.000647	CcSEcCtD
Testosterone—Hypertension—Prednisone—ankylosing spondylitis	2.7e-05	0.000646	CcSEcCtD
Testosterone—Chills—Methotrexate—ankylosing spondylitis	2.69e-05	0.000644	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	2.67e-05	0.000639	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	2.67e-05	0.000639	CcSEcCtD
Testosterone—Myalgia—Prednisone—ankylosing spondylitis	2.66e-05	0.000637	CcSEcCtD
Testosterone—Arthralgia—Prednisone—ankylosing spondylitis	2.66e-05	0.000637	CcSEcCtD
Testosterone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	2.66e-05	0.000636	CcSEcCtD
Testosterone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	2.65e-05	0.000635	CcSEcCtD
Testosterone—Anxiety—Prednisone—ankylosing spondylitis	2.65e-05	0.000634	CcSEcCtD
Testosterone—Alopecia—Methotrexate—ankylosing spondylitis	2.65e-05	0.000634	CcSEcCtD
Testosterone—Insomnia—Dexamethasone—ankylosing spondylitis	2.65e-05	0.000634	CcSEcCtD
Testosterone—Insomnia—Betamethasone—ankylosing spondylitis	2.65e-05	0.000634	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	2.64e-05	0.000632	CcSEcCtD
Testosterone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	2.63e-05	0.00063	CcSEcCtD
Testosterone—Paraesthesia—Dexamethasone—ankylosing spondylitis	2.63e-05	0.000629	CcSEcCtD
Testosterone—Paraesthesia—Betamethasone—ankylosing spondylitis	2.63e-05	0.000629	CcSEcCtD
Testosterone—Discomfort—Prednisone—ankylosing spondylitis	2.63e-05	0.000629	CcSEcCtD
Testosterone—Mental disorder—Methotrexate—ankylosing spondylitis	2.63e-05	0.000629	CcSEcCtD
Testosterone—Erythema—Methotrexate—ankylosing spondylitis	2.61e-05	0.000625	CcSEcCtD
Testosterone—Malnutrition—Methotrexate—ankylosing spondylitis	2.61e-05	0.000625	CcSEcCtD
Testosterone—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.59e-05	0.000619	CcSEcCtD
Testosterone—Urticaria—Triamcinolone—ankylosing spondylitis	2.56e-05	0.000614	CcSEcCtD
Testosterone—Urticaria—Methylprednisolone—ankylosing spondylitis	2.56e-05	0.000612	CcSEcCtD
Testosterone—Dysgeusia—Methotrexate—ankylosing spondylitis	2.56e-05	0.000612	CcSEcCtD
Testosterone—Anaphylactic shock—Prednisone—ankylosing spondylitis	2.55e-05	0.00061	CcSEcCtD
Testosterone—Oedema—Prednisone—ankylosing spondylitis	2.55e-05	0.00061	CcSEcCtD
Testosterone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	2.55e-05	0.000609	CcSEcCtD
Testosterone—Infection—Prednisone—ankylosing spondylitis	2.53e-05	0.000606	CcSEcCtD
Testosterone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	2.53e-05	0.000605	CcSEcCtD
Testosterone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	2.53e-05	0.000605	CcSEcCtD
Testosterone—Back pain—Methotrexate—ankylosing spondylitis	2.53e-05	0.000605	CcSEcCtD
Testosterone—Fatigue—Dexamethasone—ankylosing spondylitis	2.53e-05	0.000604	CcSEcCtD
Testosterone—Fatigue—Betamethasone—ankylosing spondylitis	2.53e-05	0.000604	CcSEcCtD
Testosterone—Shock—Prednisone—ankylosing spondylitis	2.51e-05	0.0006	CcSEcCtD
Testosterone—Pain—Betamethasone—ankylosing spondylitis	2.5e-05	0.000599	CcSEcCtD
Testosterone—Pain—Dexamethasone—ankylosing spondylitis	2.5e-05	0.000599	CcSEcCtD
Testosterone—Nervous system disorder—Prednisone—ankylosing spondylitis	2.5e-05	0.000599	CcSEcCtD
Testosterone—Tachycardia—Prednisone—ankylosing spondylitis	2.49e-05	0.000596	CcSEcCtD
Testosterone—Skin disorder—Prednisone—ankylosing spondylitis	2.48e-05	0.000593	CcSEcCtD
Testosterone—Hyperhidrosis—Prednisone—ankylosing spondylitis	2.47e-05	0.00059	CcSEcCtD
Testosterone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	2.42e-05	0.00058	CcSEcCtD
Testosterone—Anaemia—Methotrexate—ankylosing spondylitis	2.41e-05	0.000578	CcSEcCtD
Testosterone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	2.41e-05	0.000578	CcSEcCtD
Testosterone—Feeling abnormal—Betamethasone—ankylosing spondylitis	2.41e-05	0.000578	CcSEcCtD
Testosterone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	2.4e-05	0.000573	CcSEcCtD
Testosterone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	2.4e-05	0.000573	CcSEcCtD
Testosterone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.38e-05	0.000569	CcSEcCtD
Testosterone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.37e-05	0.000568	CcSEcCtD
Testosterone—Malaise—Methotrexate—ankylosing spondylitis	2.36e-05	0.000564	CcSEcCtD
Testosterone—Vertigo—Methotrexate—ankylosing spondylitis	2.35e-05	0.000562	CcSEcCtD
Testosterone—Urticaria—Dexamethasone—ankylosing spondylitis	2.33e-05	0.000557	CcSEcCtD
Testosterone—Urticaria—Betamethasone—ankylosing spondylitis	2.33e-05	0.000557	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	2.32e-05	0.000556	CcSEcCtD
Testosterone—Dizziness—Prednisolone—ankylosing spondylitis	2.32e-05	0.000555	CcSEcCtD
Testosterone—Asthenia—Triamcinolone—ankylosing spondylitis	2.32e-05	0.000554	CcSEcCtD
Testosterone—Abdominal pain—Dexamethasone—ankylosing spondylitis	2.32e-05	0.000554	CcSEcCtD
Testosterone—Abdominal pain—Betamethasone—ankylosing spondylitis	2.32e-05	0.000554	CcSEcCtD
Testosterone—Asthenia—Methylprednisolone—ankylosing spondylitis	2.31e-05	0.000553	CcSEcCtD
Testosterone—Insomnia—Prednisone—ankylosing spondylitis	2.31e-05	0.000552	CcSEcCtD
Testosterone—Paraesthesia—Prednisone—ankylosing spondylitis	2.29e-05	0.000548	CcSEcCtD
Testosterone—Pruritus—Triamcinolone—ankylosing spondylitis	2.28e-05	0.000546	CcSEcCtD
Testosterone—Cough—Methotrexate—ankylosing spondylitis	2.28e-05	0.000545	CcSEcCtD
Testosterone—Pruritus—Methylprednisolone—ankylosing spondylitis	2.28e-05	0.000545	CcSEcCtD
Testosterone—Arthralgia—Methotrexate—ankylosing spondylitis	2.22e-05	0.000532	CcSEcCtD
Testosterone—Chest pain—Methotrexate—ankylosing spondylitis	2.22e-05	0.000532	CcSEcCtD
Testosterone—Myalgia—Methotrexate—ankylosing spondylitis	2.22e-05	0.000532	CcSEcCtD
Testosterone—Rash—Prednisolone—ankylosing spondylitis	2.21e-05	0.00053	CcSEcCtD
Testosterone—Dermatitis—Prednisolone—ankylosing spondylitis	2.21e-05	0.000529	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.21e-05	0.000528	CcSEcCtD
Testosterone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.2e-05	0.000527	CcSEcCtD
Testosterone—Fatigue—Prednisone—ankylosing spondylitis	2.2e-05	0.000526	CcSEcCtD
Testosterone—Headache—Prednisolone—ankylosing spondylitis	2.2e-05	0.000526	CcSEcCtD
Testosterone—Discomfort—Methotrexate—ankylosing spondylitis	2.2e-05	0.000526	CcSEcCtD
Testosterone—Confusional state—Methotrexate—ankylosing spondylitis	2.15e-05	0.000514	CcSEcCtD
Testosterone—Dizziness—Triamcinolone—ankylosing spondylitis	2.13e-05	0.000511	CcSEcCtD
Testosterone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2.13e-05	0.00051	CcSEcCtD
Testosterone—Dizziness—Methylprednisolone—ankylosing spondylitis	2.13e-05	0.00051	CcSEcCtD
Testosterone—Infection—Methotrexate—ankylosing spondylitis	2.12e-05	0.000507	CcSEcCtD
Testosterone—Feeling abnormal—Prednisone—ankylosing spondylitis	2.1e-05	0.000503	CcSEcCtD
Testosterone—Asthenia—Dexamethasone—ankylosing spondylitis	2.1e-05	0.000503	CcSEcCtD
Testosterone—Asthenia—Betamethasone—ankylosing spondylitis	2.1e-05	0.000503	CcSEcCtD
Testosterone—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.09e-05	0.0005	CcSEcCtD
Testosterone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	2.09e-05	0.000499	CcSEcCtD
Testosterone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.09e-05	0.000499	CcSEcCtD
Testosterone—Nausea—Prednisolone—ankylosing spondylitis	2.09e-05	0.000499	CcSEcCtD
Testosterone—Pruritus—Betamethasone—ankylosing spondylitis	2.07e-05	0.000496	CcSEcCtD
Testosterone—Pruritus—Dexamethasone—ankylosing spondylitis	2.07e-05	0.000496	CcSEcCtD
Testosterone—Skin disorder—Methotrexate—ankylosing spondylitis	2.07e-05	0.000495	CcSEcCtD
Testosterone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	2.06e-05	0.000493	CcSEcCtD
Testosterone—Vomiting—Triamcinolone—ankylosing spondylitis	2.05e-05	0.000491	CcSEcCtD
Testosterone—Vomiting—Methylprednisolone—ankylosing spondylitis	2.05e-05	0.00049	CcSEcCtD
Testosterone—Rash—Triamcinolone—ankylosing spondylitis	2.04e-05	0.000487	CcSEcCtD
Testosterone—Dermatitis—Triamcinolone—ankylosing spondylitis	2.03e-05	0.000487	CcSEcCtD
Testosterone—Rash—Methylprednisolone—ankylosing spondylitis	2.03e-05	0.000486	CcSEcCtD
Testosterone—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.03e-05	0.000485	CcSEcCtD
Testosterone—Urticaria—Prednisone—ankylosing spondylitis	2.03e-05	0.000485	CcSEcCtD
Testosterone—Headache—Triamcinolone—ankylosing spondylitis	2.02e-05	0.000484	CcSEcCtD
Testosterone—Headache—Methylprednisolone—ankylosing spondylitis	2.02e-05	0.000483	CcSEcCtD
Testosterone—Abdominal pain—Prednisone—ankylosing spondylitis	2.02e-05	0.000482	CcSEcCtD
Testosterone—Diarrhoea—Betamethasone—ankylosing spondylitis	2e-05	0.00048	CcSEcCtD
Testosterone—Diarrhoea—Dexamethasone—ankylosing spondylitis	2e-05	0.00048	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	1.94e-05	0.000465	CcSEcCtD
Testosterone—Dizziness—Betamethasone—ankylosing spondylitis	1.94e-05	0.000463	CcSEcCtD
Testosterone—Dizziness—Dexamethasone—ankylosing spondylitis	1.94e-05	0.000463	CcSEcCtD
Testosterone—Insomnia—Methotrexate—ankylosing spondylitis	1.93e-05	0.000461	CcSEcCtD
Testosterone—Nausea—Triamcinolone—ankylosing spondylitis	1.92e-05	0.000459	CcSEcCtD
Testosterone—Paraesthesia—Methotrexate—ankylosing spondylitis	1.91e-05	0.000458	CcSEcCtD
Testosterone—Nausea—Methylprednisolone—ankylosing spondylitis	1.91e-05	0.000458	CcSEcCtD
Testosterone—Dyspnoea—Methotrexate—ankylosing spondylitis	1.9e-05	0.000455	CcSEcCtD
Testosterone—Hypersensitivity—Prednisone—ankylosing spondylitis	1.88e-05	0.00045	CcSEcCtD
Testosterone—Vomiting—Betamethasone—ankylosing spondylitis	1.86e-05	0.000446	CcSEcCtD
Testosterone—Vomiting—Dexamethasone—ankylosing spondylitis	1.86e-05	0.000446	CcSEcCtD
Testosterone—Rash—Betamethasone—ankylosing spondylitis	1.85e-05	0.000442	CcSEcCtD
Testosterone—Rash—Dexamethasone—ankylosing spondylitis	1.85e-05	0.000442	CcSEcCtD
Testosterone—Dermatitis—Dexamethasone—ankylosing spondylitis	1.85e-05	0.000441	CcSEcCtD
Testosterone—Dermatitis—Betamethasone—ankylosing spondylitis	1.85e-05	0.000441	CcSEcCtD
Testosterone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	1.84e-05	0.00044	CcSEcCtD
Testosterone—Fatigue—Methotrexate—ankylosing spondylitis	1.84e-05	0.00044	CcSEcCtD
Testosterone—Headache—Betamethasone—ankylosing spondylitis	1.83e-05	0.000439	CcSEcCtD
Testosterone—Headache—Dexamethasone—ankylosing spondylitis	1.83e-05	0.000439	CcSEcCtD
Testosterone—Asthenia—Prednisone—ankylosing spondylitis	1.83e-05	0.000438	CcSEcCtD
Testosterone—Pain—Methotrexate—ankylosing spondylitis	1.82e-05	0.000436	CcSEcCtD
Testosterone—Pruritus—Prednisone—ankylosing spondylitis	1.8e-05	0.000432	CcSEcCtD
Testosterone—Feeling abnormal—Methotrexate—ankylosing spondylitis	1.76e-05	0.00042	CcSEcCtD
Testosterone—Diarrhoea—Prednisone—ankylosing spondylitis	1.75e-05	0.000418	CcSEcCtD
Testosterone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	1.74e-05	0.000417	CcSEcCtD
Testosterone—Nausea—Betamethasone—ankylosing spondylitis	1.74e-05	0.000416	CcSEcCtD
Testosterone—Nausea—Dexamethasone—ankylosing spondylitis	1.74e-05	0.000416	CcSEcCtD
Testosterone—Urticaria—Methotrexate—ankylosing spondylitis	1.69e-05	0.000405	CcSEcCtD
Testosterone—Dizziness—Prednisone—ankylosing spondylitis	1.69e-05	0.000404	CcSEcCtD
Testosterone—Abdominal pain—Methotrexate—ankylosing spondylitis	1.69e-05	0.000403	CcSEcCtD
Testosterone—Vomiting—Prednisone—ankylosing spondylitis	1.62e-05	0.000388	CcSEcCtD
Testosterone—Rash—Prednisone—ankylosing spondylitis	1.61e-05	0.000385	CcSEcCtD
Testosterone—Dermatitis—Prednisone—ankylosing spondylitis	1.61e-05	0.000384	CcSEcCtD
Testosterone—Headache—Prednisone—ankylosing spondylitis	1.6e-05	0.000382	CcSEcCtD
Testosterone—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.57e-05	0.000376	CcSEcCtD
Testosterone—Asthenia—Methotrexate—ankylosing spondylitis	1.53e-05	0.000366	CcSEcCtD
Testosterone—Nausea—Prednisone—ankylosing spondylitis	1.52e-05	0.000363	CcSEcCtD
Testosterone—Pruritus—Methotrexate—ankylosing spondylitis	1.51e-05	0.000361	CcSEcCtD
Testosterone—Diarrhoea—Methotrexate—ankylosing spondylitis	1.46e-05	0.000349	CcSEcCtD
Testosterone—Dizziness—Methotrexate—ankylosing spondylitis	1.41e-05	0.000337	CcSEcCtD
Testosterone—Vomiting—Methotrexate—ankylosing spondylitis	1.36e-05	0.000324	CcSEcCtD
Testosterone—Rash—Methotrexate—ankylosing spondylitis	1.34e-05	0.000322	CcSEcCtD
Testosterone—Dermatitis—Methotrexate—ankylosing spondylitis	1.34e-05	0.000321	CcSEcCtD
Testosterone—Headache—Methotrexate—ankylosing spondylitis	1.34e-05	0.00032	CcSEcCtD
Testosterone—Nausea—Methotrexate—ankylosing spondylitis	1.27e-05	0.000303	CcSEcCtD
